Medical Oncology

, Volume 12, Issue 3, pp 149–156 | Cite as

Autologous graft-versus-host disease

  • M. John Kennedy
  • Allan D. Hess


autologous bone marrow support apoptosis graft-versus-host 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yeager, A.M., Kaizer, H., Santos, al. (1986) Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, usingex-vivo marrow treatment with 4-hydroperoxycyclophosphamide.N. Engl. J. Med. 315, 141–7.PubMedGoogle Scholar
  2. 2.
    Jones, R.J., Piantadosi, S., Mann, al. (1990) High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkins disease.J. Clin. Oncol. 8, 527–37.PubMedGoogle Scholar
  3. 3.
    Kennedy, M.J., Beveridge, R.A., Rowley, al. (1991) High-dose chemotherapy with reinfusion of purged autologous marrow following dose-intense induction as initial therapy for metastatic breast cancer.J. Natl. Cancer Inst. 83, 920–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Peters, W.P., Berry, D., Vredenburgh, al. (1995) Five year follow up of high-dose combination alkylating agents with ABMT as consolidation after standard-dose CAF for primary breast cancer involving ≥10 axillary lymph nodes.Proc. Am. Soc. Clin. Oncol. 14, 933 (Abstract).Google Scholar
  5. 5.
    Passos-Coelho, J.-L., Braine, H.G., Davis, al. (1995) Predictive factors for peripheral blood progenitor cell (PBPC) collections using a single large volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony stimulating factor (GM-CSF) mobilization.J. Clin. Oncol. 13, 705–14.PubMedGoogle Scholar
  6. 6.
    Jones, R.J., Bedi, A., Miller, al. (1993) Inhibition of apoptosis: A novel mechanism of resistance to multiple cytotoxic agents in acute myeloid leukemia.Exp. Hematol. 21, 1078 (Abstract).Google Scholar
  7. 7.
    Bedi, A., Barber, J.P., Bedi, al. BCR-ABL-mediated inhibition of apoptosis by delay of G2/M transition following DNA damage: A mechanism of resistance to multiple anticancer agents.Blood (in press).Google Scholar
  8. 8.
    Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D. (1993) P53-dependent apoptosis modulates the cytotoxicity of anticancer agents.Cell 7, 957–67.CrossRefGoogle Scholar
  9. 9.
    Collins, M.K.L., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992) Interleukin-3 protests murine bone marrow cells from apoptosis induced by DNA damaging agents.J. Exp. Med. 176, 1043–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Fuchs, E.J., Bedi, A., Jones, R.J. and Hess, A.D. (1995) Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.Cancer Res. 55, 463–6.PubMedGoogle Scholar
  11. 11.
    Vaux, D.L., Aguila, H.L. and Weissman, I.L. (1992) Bcl-2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell mediated killing.Int. Immunol. 4, 821–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Kersey, J.H., Weisdorf, D., Nesbit, al. (1987) Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.N. Engl. J. Med. 317, 461–7.PubMedGoogle Scholar
  13. 13.
    Weiden, P.L., Fluornoy, N., Thomas, al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.N. Engl. J. Med. 300, 1068–73.PubMedGoogle Scholar
  14. 14.
    Weiden, P.L., Sullivan, K.M., Fluornoy, N., Storb, R. and Thomas, E.D. (1981) Antileukemic effect of graft versus host disease. Contribution to improved survival after allogeneic marrow transplantation.N. Engl. J. Med. 304, 1529–33.PubMedGoogle Scholar
  15. 15.
    Butturini, A., Bortin, M.M. and Gale, R.P. (1987) Graft-versus-leukemia following bone marrow transplantation.Bone Marrow Transpl. 2, 233–42.Google Scholar
  16. 16.
    Horowitz, M.M., Gale, R.P., Sondel, al. (1990) Graft-versus-leukemia reactions after bone marrow transplantation.Blood 75, 555–62.PubMedGoogle Scholar
  17. 17.
    Jones, R.J., Ambinder, R.F., Piantadosi, S. and Santos, G.W. (1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.Blood 77, 649–53.PubMedGoogle Scholar
  18. 18.
    Santos, G.W. (1970) Effect of graft-versus-host-disease on a spontaneous adenocarcinoma in mice.Exp. Hematol. 20, 46–8.Google Scholar
  19. 19.
    Fefer, A. (1970) Immunotherapy of primary Moloney sarcoma virus-induced tumors.Int. J. Cancer 5, 327–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Foon, K.A. and Todd, R.F. III. (1986) Immunologic classification of leukemia and lymphoma.Blood 68, 1–31.PubMedGoogle Scholar
  21. 21.
    Zuk, J.A. and Walker, R.A. (1988) HLA class II sublocus expression in benign and malignant breast epithelium.J. Pathol. 155, 301–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Gastl, G., Marth, C., Leiter, al. Effects of human recombinantα 2 arg-interferon andγ-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.Cancer Res. 45, 2957-61.Google Scholar
  23. 23.
    Glazier, A., Tutschka, P.J., Farmer, E.R. and Santos, G.W. (1983) Graft-versus-host disease in cyclosporine A treated rats after syngeneic and autologous bone marrow transplantation.J. Exp. Med. 158, 1–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Glazier, A. Tutschka, P.J. and Farmer, E.R. (1983) Studies on the immunobiology of syngeneic and autologous graft-versus-host disease in cyclosporine treated rats.Transplant. Proc. 15, 3035.Google Scholar
  25. 25.
    Beschorner, W.E., Shinn, C.A., Fischer, A.C., Santos, G.W. and Hess, A.D. (1988) Cyclosporine-induced pseudo-graft-versus-host disease in the early post-cyclosporine period.Transplantation 46, 112–7.CrossRefGoogle Scholar
  26. 26.
    Hess, A.D., Horwitz, L., Beschorner, W.E. and Santos, G.W. (1985) Development of graft-versus-host disease like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation.J. Exp. Med. 161, 718–30.PubMedCrossRefGoogle Scholar
  27. 27.
    Sorokin, R., Kimura, H., Schroder, K. and Wilson, D.B. (1986) Cyclosporine-induced autoimmunity: Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.J. Exp. Med. 164, 1615–25.PubMedCrossRefGoogle Scholar
  28. 28.
    Jenkins, M.K., Schwartz, R.H. and Pardoll, D.M. (1988) Effects of cyclosporine A on T cell development and clonal deletion.Science 241, 1655–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Hess, A.D. and Fischer, A.C. (1989) Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.Transplantation 48, 895–900.PubMedCrossRefGoogle Scholar
  30. 30.
    Hess, A.D., Fischer, A.C. and Beschorner, W.E. (1990) Effector mechanisms in cyclosporine A induced syngeneic graft-versus-host disease: Role of CD4+ and CD8+ T lymphocyte subsets.J. Immunol. 145, 526–33.PubMedGoogle Scholar
  31. 31.
    Morris, L.M., Vogelsang, G.B., Bright, E.C., Jones, R.J., Santos, G.W. and Hess, A.D. (1993) Immune Reconstitution in cyclosporine-induced autologous GVHD.Blood 80, 136 (Abstract).Google Scholar
  32. 32.
    Geller, G.B., Esa, A.H., Beschorner, W.E., Frondoza, C.G., Santos, G.W. and Hess, A.D. (1989) Successfulin vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.Blood 74, 1165–71.PubMedGoogle Scholar
  33. 33.
    Fischer, A.C., Ruvolo, P.P., Burt, al. (1995) Characterization of the autoreactive T cell repertoire in cyclosporine-induced syngeneic graft-versus-host disease.J. Immunol. 154, 3713–25.PubMedGoogle Scholar
  34. 34.
    Fischer, A.C., Ruvolo, P.P., Horwitz, L.R. and Hess, A.D. (1995) Analysis of Vβ T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.Transplant. Proc. 27, 1366–9.PubMedGoogle Scholar
  35. 35.
    Hess, A.D., Jones, R., Vogelsang, G.B. and Santos, G.W. (1991) Syngeneic graft-versus-host disease: Fundamental mechanisms and clinical applications. In R. Gale and R. Champlin (eds)New Strategies in Bone Marrow Transplantation, pp. 61–72. New York, Wiley.Google Scholar
  36. 36.
    Jones, R.J., Vogelsang, G.B., Hess, al. (1989) Induction of graft-versus-host disease after autologous bone marrow transplantation.Lancet 1, 754–57.PubMedCrossRefGoogle Scholar
  37. 37.
    Jones, R.J., Vogelsang, G.B., Ambinder, R.F., Santos, G.W. and Hess, A.D. (1991) Autologous marrow transplantation (ABMT) with cyclosporine (CSA)-induced autologous graft-versus-host disease (GVHD) for relapsed aggressive non-Hodgkins lymphoma (NHL).Blood 78, 287 (Abstract).Google Scholar
  38. 38.
    Philip, T., Armitage, J.O., Spitzer, al. (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkins lymphoma.N. Engl. J. Med. 316, 1493–8.PubMedGoogle Scholar
  39. 39.
    Yeager, A.M., Vogelsang, G.B., Jones, al. (1992) Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.Blood 79, 3031–5.PubMedGoogle Scholar
  40. 40.
    Bernard, D., Maurizis, J.-C., Ruse, F., Chassagne, J., Chollet, P., Sauvezie, B., De Latour, M. and Plagne, R. (1984) Presence of HLA-D/DR antigens on the membrane of breast tumor cells.Clin. Exp. Immunol. 56, 215–21.PubMedGoogle Scholar
  41. 41.
    Natali, P.G., Giacomini, P., Bigotti, al. (1983) Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.Cancer Res. 43, 660–8.PubMedGoogle Scholar
  42. 42.
    Whitwell, H.L., Hughes, H.P.A., Moore, M. and Ahmed, A. (1984) Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.Br. J. Cancer 49, 161–172.PubMedGoogle Scholar
  43. 43.
    Kennedy, M.J., Vogelsang, G.B., Beveridge, al. (1993) Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer.J. Clin. Oncol. 11, 478–4.PubMedGoogle Scholar
  44. 44.
    Schwartz, R., Momburg, F., Moldenhauer, G., Dorken, B. and Schirrmacher, V. (1985) Induction of HLA Class-II antigen expression on human carcinoma cell lines by IFN-gamma.Int. J. Cancer 35, 245–50.PubMedCrossRefGoogle Scholar
  45. 45.
    Dolei, A., Capobianchi, M.R. and Ameglio, F. (1983) Humanγ-interferon enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively thanα-interferon andβ-interferon.Infect. Immunol. 40, 172–6.Google Scholar
  46. 46.
    Kennedy, M.J., Vogelsang, G.B., Jones, al. (1994) Phase I trial of interferon-gamma to potentiate cyclosporine A-induced graft-versus-host-disease in women under-going autologous bone marrow transplantation for breast cancer.J. Clin. Oncol. 12, 249–57.PubMedGoogle Scholar
  47. 47.
    Ruvolo, P., Bright, E., Kennedy, al. (1995) Cyclosporine-induced autologous graft versus host disease: Assessment of cytolytic effector mechanisms and the Vβ T-cell receptor repertoire.Transplant. Proc. 27, 1363–5.PubMedGoogle Scholar
  48. 48.
    Kennedy, M.J., Hess, A.D., Passos-Coehlo, al. (1995) Peripheral blood progenitor cell infusions do not inhibit the induction of autologous graft-vs-host disease by cyclosporine a following high-dose chemotherapy.Proc. Am. Soc. Clin. Oncol. 14, 915 (Abstract).Google Scholar

Copyright information

© Humana Press Inc. 1995

Authors and Affiliations

  • M. John Kennedy
    • 1
  • Allan D. Hess
    • 1
  1. 1.The Johns Hopkins Oncology CenterBaltimoreUSA

Personalised recommendations